In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Peru quake: equipment and laboratories among key needs

This article was originally published in Clinica

Replacing A&E equipment and restoring essential health services, including the laboratory testing that supports disease surveillance, are among the top priorities of recovery efforts in Peru's earthquake-stricken Ica region. Efforts are underway to define such needs and centrally co-ordinate the logistics involved. The WHO is setting up an information-sharing system to support these activities.

"Re-establishing local health services, emergency medical equipment and the epidemiological surveillance system are the current top priorities," said Dr Jean-Luc Poncelet, head of emergency preparedness and disaster relief at PAHO, on August 20.

There has been widespread and severe damage to "numerous hospitals and health centres", reports the Pan-American Health Organization (PAHO), including the total destruction of several hospitals and other facilities in and around the cities of Pisco and regional capital Ica, near the epicentre. Three health centres were destroyed as far as the remote cities of Castrovirreyna and Huancavelica. Further structural and functional assessments are underway.

At the time of going to press, PAHO told Clinica that a command centre was being set up, and that the health ministry would begin to provide daily updates of relief needs "within the next couple of days".

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT049509

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel